Australia · Delayed Price · Currency is AUD Argent BioPharma Statistics
Total Valuation
ASX:RGT has a market cap or net worth of AUD 3.73 million. The enterprise value is 13.18 million.
| Market Cap | 3.73M |
| Enterprise Value | 13.18M |
Important Dates
The last earnings date was Friday, September 4, 2026.
| Earnings Date | Sep 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ASX:RGT has 116.61 million shares outstanding. The number of shares has increased by 51.69% in one year.
| Current Share Class | 116.61M |
| Shares Outstanding | 116.61M |
| Shares Change (YoY) | +51.69% |
| Shares Change (QoQ) | +27.50% |
| Owned by Insiders (%) | 22.53% |
| Owned by Institutions (%) | 0.72% |
| Float | 43.68M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 23.15 |
| PB Ratio | -0.40 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 81.76 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.05
| Current Ratio | 0.05 |
| Quick Ratio | 0.04 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -2.38 |
| Interest Coverage | -220.79 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -247.26% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 102.71% |
| Weighted Average Cost of Capital (WACC) | 2.01% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.09 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -77.14% in the last 52 weeks. The beta is 0.40, so ASX:RGT's price volatility has been lower than the market average.
| Beta (5Y) | 0.40 |
| 52-Week Price Change | -77.14% |
| 50-Day Moving Average | 0.04 |
| 200-Day Moving Average | 0.05 |
| Relative Strength Index (RSI) | 39.73 |
| Average Volume (20 Days) | 237,983 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ASX:RGT had revenue of AUD 161,187 and -7.71 million in losses. Loss per share was -0.09.
| Revenue | 161,187 |
| Gross Profit | -39,618 |
| Operating Income | -7.44M |
| Pretax Income | -7.71M |
| Net Income | -7.71M |
| EBITDA | -7.40M |
| EBIT | -7.44M |
| Loss Per Share | -0.09 |
Balance Sheet
The company has 141,456 in cash and 9.59 million in debt, with a net cash position of -9.45 million or -0.08 per share.
| Cash & Cash Equivalents | 141,456 |
| Total Debt | 9.59M |
| Net Cash | -9.45M |
| Net Cash Per Share | -0.08 |
| Equity (Book Value) | -9.45M |
| Book Value Per Share | -0.09 |
| Working Capital | -8.08M |
Cash Flow
In the last 12 months, operating cash flow was -4.03 million and capital expenditures -1,612, giving a free cash flow of -4.03 million.
| Operating Cash Flow | -4.03M |
| Capital Expenditures | -1,612 |
| Depreciation & Amortization | 47,221 |
| Net Borrowing | 2.88M |
| Free Cash Flow | -4.03M |
| FCF Per Share | -0.03 |
Margins
| Gross Margin | -24.58% |
| Operating Margin | -4,617.46% |
| Pretax Margin | -4,783.36% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ASX:RGT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -51.69% |
| Shareholder Yield | -51.69% |
| Earnings Yield | -206.62% |
| FCF Yield | -107.91% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 30, 2023. It was a reverse split with a ratio of 0.001.
| Last Split Date | Oct 30, 2023 |
| Split Type | Reverse |
| Split Ratio | 0.001 |
Scores
ASX:RGT has an Altman Z-Score of -193.85 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -193.85 |
| Piotroski F-Score | 3 |